# Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

> **NCT00006890** · PHASE2 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 67 (actual)

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **DRUG:** prednisone
- **DRUG:** thalidomide

## Key facts

- **NCT ID:** NCT00006890
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07-12
- **Primary completion:** 2002-05-03
- **Final completion:** 2008-12-15
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2020-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006890, "Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00006890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*